Cardinal Health, Inc. · NYSE:CAH

Cardinal Health — 39th Annual J.P. Morgan Healthcare Conference (January 2021)

21 slides from Cardinal Health's conference presentation, Jan 11, 2021

  1. Slide 1: Cardinal Health, Inc. 39th Annual JP Morgan Conference

    Cardinal Health, Inc. 39th Annual JP Morgan Conference Mike Kaufmann Chief Executive Officer January 11, 2021

  2. Slide 2: Forward-looking statements and GAAP reconciliation

    Forward-looking statements and GAAP reconciliation Cautions Concerning Forward-Looking Statements This presentation contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be ident

  3. Slide 3: We are

    We are 3 © 2021 Cardinal Health. All Rights Reserved.

  4. Slide 4: Driving growth to advance healthcare and improve lives

    Driving growth Driving to advance healthcare growth to and improve advance healthcare lives and improve lives Globally integrated Creating patient-centric healthcare services and solutions products company so our customers can address a distributor of pharmaceuticals; healthcare’s most global manufa

  5. Slide 5: Essential facts about Cardinal Health

    Essential facts about Cardinal Health Approximately $153B Operations in more than 48,000 of revenue in FY20 40 countries employees worldwide 5 © 2021 Cardinal Health. All Rights Reserved.

  6. Slide 6: Our breadth and scale

    Our breadth and scale We serve roughly 90% Every day, we serve We serve more than We manufacture and We serve more of U.S. hospitals through more than 29,000 U.S. 3.4 million U.S. distribute more than than 10,000 U.S. our pharmaceutical or pharmacies. These include patients with more 50,000 types of

  7. Slide 7: Consistent track record

    Consistent track record FY19 FY20 Grow non-GAAP EPS; exceed initial guidance range Exceed enterprise cost savings target Strengthen balance sheet through debt paydown Make strategic portfolio decisions1 Return cash to shareholders 1 FY19: Acquisitions of Mirixa® and mscripts®. FY20: Divested minorit

  8. Slide 8: FY20 financial summary

    FY20 financial summary Revenue ($M) $152,922 % change +5% Non-GAAP Operating Earnings1,2 ($M) $2,384 % change +1% Non-GAAP Diluted EPS2,3 $5.45 % change +3% Operating Cash Flow ($B) $2.0 1FY20 GAAP operating loss was $(4,098)M 2GAAP results include a pre-tax charge of $5.63 billion ($5.14 billion af

  9. Slide 9: Two financial reporting segments

    Two financial reporting segments Pharmaceutical Medical FY20 FY20 FY20 FY20 revenues segment profit revenues segment profit $137.5B $1.8B $15.4B $663M 9 © 2021 Cardinal Health. All Rights Reserved.

  10. Slide 10: Pharmaceutical segment

    Pharmaceutical segment Key capabilities • Distribute branded, generic, and specialty pharmaceuticals and over-the-counter healthcare and consumer products Pharmaceutical Distribution • Provide end-to-end logistics and technology solutions for Specialty Solutions manufacturers, pharmacies and healthc

  11. Slide 11: Medical segment

    Medical segment Key capabilities • Manufacture, source, and distribute Cardinal Health branded medical, surgical, and laboratory products Medical Products • Distribute a broad range of national brand medical, surgical, Medical Products Distribution and laboratory products to acute and alternate site

  12. Slide 12: Demonstrating resilience

    Demonstrating resilience Key COVID-19 responses • Maintained operations in all distribution facilities, nuclear pharmacies, and global manufacturing plants • Leveraged Red Oak’s sourcing capabilities to minimize disruptions to the pharmaceutical supply chain • Acquired additional equipment to expand

  13. Slide 13: Strategic priorities

    Strategic priorities • Optimize core businesses • Invest for growth • Deploy capital efficiently • Enhance our global • Prioritize investment in • Specialty Solutions the business supply chain and drive commercial excellence • Cardinal Health at- • Maintain a strong Home Solutions • Maximize all asp

  14. Slide 14: Our differentiated portfolio

    Our differentiated portfolio Our differentiated portfolio blends core distribution and product offerings with strategic assets positioned for strong growth Investing for growth in areas with: • Favorable industry trends and Specialty at-Home strong outlooks Solutions Solutions Optimizing core • Comp

  15. Slide 15: Deploy capital in a disciplined and thoughtful way

    Deploy capital in a disciplined and thoughtful way Capital allocation priorities Focused on maintaining flexibility and generating significant long-term value Investing in key areas of our business to enable Invest in the business our strong pipeline for organic growth Higher Priority Committed to t

  16. Slide 16: Cardinal Health investment thesis

    Cardinal Health investment thesis • Resilient business models ̶ Expected growth in both segments despite COVID-19 headwind of lower volumes • Increasing healthcare demand ̶ Favorable healthcare trends and patient demographics increase demand for our services • Focused on driving efficiencies ̶ On pa

  17. Slide 17: We are

    We are 17 © 2021 Cardinal Health. All Rights Reserved.

  18. Slide 18: Appendix

    Appendix GAAP to non-GAAP reconciliation statements and supplemental financial information

  19. Slide 19: GAAP / Non-GAAP Reconciliation

    Cardinal Health, Inc. and Subsidiaries 1 GAAP / Non-GAAP Reconciliation Operating Earnings/ Net Gross Earnings/ (Loss) Provision for/ Earnings/ Diluted Margin SG&A2 Operating (Loss) Before (Benefit from) Net (Loss)3 Effective EPS3 Gross Growth Growth Earnings/ Growth Income Income Earnings/ Growth T

  20. Slide 20: Forward Looking non-GAAP Measures

    Cardinal Health, Inc. and Subsidiaries Forward Looking non-GAAP Measures In this document, the Company presents certain forward-looking non-GAAP metrics. The Company does not provide outlook on a GAAP basis because the items that the Company excludes from GAAP to calculate the comparable non-GAAP me

  21. Slide 21: Definitions

    Cardinal Health, Inc. and Subsidiaries Definitions Growth rate calculation: growth rates are determined by dividing the difference between current-period results and prior-period results by prior-period results. Interest and Other, net: other (income)/expense, net plus interest expense, net. Segment

Cardinal Health — 39th Annual J.P. Morgan Healthcare Conference (January 2021) on 6ix